Quick Overview: Episode breakdown: 00:00 – Intro: Why April Was a Pivotal From billion dollar M&A to FDA greenlights and the next wave of surgical AI, August was packed with major stories in Welcome back! Today, we're pitting two titans of heart technology against each other:

This Month In Medtech Edwards - Detailed Overview & Context

Episode breakdown: 00:00 – Intro: Why April Was a Pivotal From billion dollar M&A to FDA greenlights and the next wave of surgical AI, August was packed with major stories in Welcome back! Today, we're pitting two titans of heart technology against each other: In this special conversation at AEM Malta 2025, That's exactly what Filippo Piatti, CEO of ARTINESS, is building—a software-as-a-medical-device platform that merges ...

Photo Gallery

This Month in Medtech: Edwards’ Big Move, $200M Robotics Bet & AI Shifts
This Month in MedTech 2026: Cardiovascular M&A, Medtronic’s $100M Bet, and the Platform Wars
This Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the Move
Edwards Lifesciences (EW) vs. Medtronic PLC (MDT)
𝗙𝗗𝗔 𝗔𝗣𝗣𝗥𝗢𝗩𝗘𝗦 𝗦𝗔𝗣𝗜𝗘𝗡 𝗠𝟯: 𝗠𝗜𝗡𝗜𝗠𝗔𝗟𝗟𝗬 𝗜𝗡𝗩𝗔𝗦𝗜𝗩𝗘 𝗠𝗜𝗧𝗥𝗔𝗟 𝗩𝗔𝗟𝗩𝗘 𝗕𝗥𝗘𝗔𝗞𝗧𝗛𝗥𝗢𝗨𝗚𝗛
Pioneer in Endoscopic Innovation Award | Prof. Edward Despott. at  MedTech Malta awards 2025
MedTech Insights with Guests Alisa Niksch, MD, & Jamey Edwards, MBA
From London to Malta: Prof. Edward Despott on Advancing Endoscopy Globally
Google Maps for Heart Surgery? | ARTINESS CEO at MedTech World
Edwards Lifesciences: Revolutionizing Heart Health with Innovation
Edwards Lifesciences (EW) Stock Analysis 2026 – Graphs, Risks, Opportunities & Valuation ✅
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored